Clinical Course and Predictable Factors for Remission of Hashimoto' Thyroiditis in Children and Adolescents.
- Author:
Keun Hye LEE
;
Mi Jung KIM
;
Heon Seok HAN
- Publication Type:Original Article
- Keywords:
Hashimoto' thyroiditis;
Goiter;
Thyroid function status;
Antithyroglobulin antibody;
Antimicrosomal antibody
- MeSH:
Adolescent*;
Child*;
Diagnosis;
Female;
Follow-Up Studies;
Goiter;
Humans;
Retrospective Studies;
Thyroid Gland*;
Thyroiditis*
- From:Journal of Korean Society of Pediatric Endocrinology
2004;9(1):34-41
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE:The natural course of Hashimoto' thyroiditis (HT) is so dynamic that the disease progresses to overt hypothyroid or spontaneous recovery. The authors reviewed the clinical course of this disease and analysed the possible predicting factors regarding remission. METHODS:Thirty nine patients with HT (38 girls and 1 boy) were studied retrospectively. Of these patients, 30 were followed for more than 2 years. The possible remission factors were analyzed at initial diagnosis and during follow-up period. RESULTS:The mean age at the diagnosis was 11.8+/-.1 years. Initial thyroid function was euthyroid in 38.5%, compensated hypothyroid in 35.9%, overt hypothyroid in 23.1%, and hyperthyroid in 2.6% of patients. Antithyroglobulin antibody (ATA) was positive in 94.7%, and antimicrosomal antibody (AMA) was positive in 74.4%. The overall remission rate was 53.3% during the follow-up period (51+/-7 months). Initial goiter size, thyroid function status, and autoantibody titer had no relation to the remission rate statistically. Follow-up autoantibody titers in remission group were marginally lower than those in nonremission group (P<0.1), and follow-up AMA titer was significantly higher than initial titers in nonremission group (P<0.05). CONCLUSION: We could not find any predictable remission factors from the initial clinical and autoantibody status. But, during follow-up period, patients with lower autoantibody titers showed slight higher remission, and those with increasing AMA titer showed less remission. Above results suggest that we should monitor antithyroid antibody titer as well as thyroid function regularly.
